166 related articles for article (PubMed ID: 25339682)
1. Effects of chronic kidney disease on liver transport: quantitative intravital microscopy of fluorescein transport in the rat liver.
Ryan JC; Dunn KW; Decker BS
Am J Physiol Regul Integr Comp Physiol; 2014 Dec; 307(12):R1488-92. PubMed ID: 25339682
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of hepatic transporters using intravital microscopy.
Weiss M; Liu X; Thorling CA; Roberts MS
Eur J Pharm Sci; 2013 Aug; 49(5):845-9. PubMed ID: 23791640
[TBL] [Abstract][Full Text] [Related]
3. Intravital multiphoton microscopy can model uptake and excretion of fluorescein in hepatic ischemia-reperfusion injury.
Thorling CA; Liu X; Burczynski FJ; Fletcher LM; Roberts MS; Sanchez WY
J Biomed Opt; 2013 Oct; 18(10):101306. PubMed ID: 23812606
[TBL] [Abstract][Full Text] [Related]
4. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.
Donner MG; Schumacher S; Warskulat U; Heinemann J; Häussinger D
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1134-46. PubMed ID: 17916651
[TBL] [Abstract][Full Text] [Related]
5. How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver.
Millet P; Moulin M; Stieger B; Daali Y; Pastor CM
J Pharmacol Exp Ther; 2011 Mar; 336(3):624-32. PubMed ID: 21131269
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
7. Small hepatocytes in culture develop polarized transporter expression and differentiation.
Sidler Pfändler MA; Höchli M; Inderbitzin D; Meier PJ; Stieger B
J Cell Sci; 2004 Aug; 117(Pt 18):4077-87. PubMed ID: 15280430
[TBL] [Abstract][Full Text] [Related]
8. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
9. Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats.
Dunn KW; Ryan JC
Methods; 2017 Sep; 128():40-51. PubMed ID: 28434905
[TBL] [Abstract][Full Text] [Related]
10. Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver.
Chandra P; Johnson BM; Zhang P; Pollack GM; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1238-43. PubMed ID: 15908472
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
[TBL] [Abstract][Full Text] [Related]
12. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic renal failure on liver drug transporters.
Naud J; Michaud J; Leblond FA; Lefrancois S; Bonnardeaux A; Pichette V
Drug Metab Dispos; 2008 Jan; 36(1):124-8. PubMed ID: 17940133
[TBL] [Abstract][Full Text] [Related]
14. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
Su Y; Zhang X; Sinko PJ
Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
[TBL] [Abstract][Full Text] [Related]
15. Altered Expression and Function of Hepatic Transporters in a Rodent Model of Polycystic Kidney Disease.
Bezençon J; Beaudoin JJ; Ito K; Fu D; Roth SE; Brock WJ; Brouwer KLR
Drug Metab Dispos; 2019 Aug; 47(8):899-906. PubMed ID: 31160314
[TBL] [Abstract][Full Text] [Related]
16. Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.
Kawase A; Handa A; Iwaki M
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):519-526. PubMed ID: 27511381
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cryopreservation on Enzyme and Transporter Activities in Suspended and Sandwich Cultured Rat Hepatocytes.
Keemink J; Deferm N; De Bruyn T; Augustijns P; Bouillon T; Annaert P
AAPS J; 2018 Feb; 20(2):33. PubMed ID: 29468289
[TBL] [Abstract][Full Text] [Related]
18. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
19. Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity.
Weigand KM; Schirris TJJ; Houweling M; van den Heuvel JJMW; Koenderink JB; Dankers ACA; Russel FGM; Greupink R
Toxicol In Vitro; 2019 Apr; 56():52-61. PubMed ID: 30639138
[TBL] [Abstract][Full Text] [Related]
20. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver.
Paulusma CC; Kothe MJ; Bakker CT; Bosma PJ; van Bokhoven I; van Marle J; Bolder U; Tytgat GN; Oude Elferink RP
Hepatology; 2000 Mar; 31(3):684-93. PubMed ID: 10706559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
